Retrograde versus antegrade percutaneous aortic balloon valvuloplasty: Immediate, short- and long-term outcome at 2 years

Catheterization and Cardiovascular Interventions

Volumn 74, Issue 2, 2009, Pages 225-231

  Cubeddu, Roberto J ^a   Jneid, Hani ^a   Don, Creighton W ^a   Witzke, Christian F ^a   Cruz Gonzalez, Ignacio ^a   Gupta, Rakesh ^a   Rengifo Moreno, Pablo ^a   Maree, Andrew O ^a   Inglessis, Ignacio ^a   Palacios, Igor F ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Antegrade; Percutaneous aortic balloon valvuloplasty; Retrograde; Vascular complications

Indexed keywords

AGED; AORTA BALLOON; AORTA VALVE REPLACEMENT; ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY DISEASE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERTENSION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PERIPHERAL VASCULAR DISEASE; SMOKING; SURGICAL APPROACH; SURGICAL MORTALITY; SURGICAL TECHNIQUE; SURVIVAL TIME; TRANSLUMINAL VALVULOPLASTY; TREATMENT INDICATION;

AGED; AGED, 80 AND OVER; AORTIC VALVE; BALLOON DILATION; CARDIOVASCULAR DISEASES; FEASIBILITY STUDIES; FEMALE; HEART VALVE DISEASES; HEMODYNAMICS; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; RADIOGRAPHY, INTERVENTIONAL; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 70349503532     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.22085     Document Type: Article

References (21)

1. Moreno PR, Jang IK, Newell JB, Block PC, Palacios IF. The role of percutaneous aortic balloon valvuloplasty in patients with cardiogenic shock and critical aortic stenosis. J Am Coll Cardiol 1994;23:1071-1075.
2. Bonow RO, Carabello BA, Kanu C, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): Developed in collaboration with the Society of Cardiovascular Anesthesiologists: Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 2006;114:e84-e231.
3. Ferguson JJ III, Riuli EP, Massumi A, Treistman B, Edelman SK, Harlan MV, Brasier SE, Murgo JP. Balloon aortic valvuloplasty: The Texas Heart Institute experience. Tex Heart Inst J 1990;17:23-30.
4. Lieberman EB, Bashore TM, Hermiller JB, Wilson JS, Pieper KS, Keeler GP, Pierce CH, Kisslo KB, Harrison JK, Davidson CJ. Balloon aortic valvuloplasty in adults: Failure of procedure to improve long-term survival. J Am Coll Cardiol 1995;26: 1522-1528.
5. Otto CM, Mickel MC, Kennedy JW, et al. Three-year outcome after balloon aortic valvuloplasty. Insights into prognosis of valvular aortic stenosis. Circulation 1994;89:642-650.
6. Davidson CJ, Harrison JK, Leithe ME, Kisslo KB, Bashore TM. Failure of balloon aortic valvuloplasty to result in sustained clinical improvement in patients with depressed left ventricular function. Am J Cardiol 1990;65:72-77.
7. Cribier A, Remadi F, Koning R, Rath P, Stix G, Letac B. Emergency balloon valvuloplasty as initial treatment of patients with aortic stenosis and cardiogenic shock. N Engl J Med 1992; 326:646.
8. Block PC, Palacios IF. Comparison of hemodynamic results of anterograde versus retrograde percutaneous balloon aortic valvuloplasty. Am J Cardiol 1987;60:659-662.
9. Sakata Y, Syed Z, Salinger MH, Feldman T. Percutaneous balloon aortic valvuloplasty: Antegrade transseptal vs. conventional retrograde transarterial approach. Catheter Cardiovasc Interv 2005;64:314-321.
10. Eisenhauer AC, Hadjipetrou P, Piemonte TC. Balloon aortic valvuloplasty revisited: The role of the inoue balloon and transseptal antegrade approach. Catheter Cardiovasc Interv 2000;50: 484-491.
11. Nashef SA, Roques F, Hammill BG, Peterson ED, Michel P, Grover FL, Wyse RK, Ferguson TB. Validation of European System for Cardiac Operative Risk Evaluation (EuroSCORE) in North American cardiac surgery. Eur J Cardiothorac Surg 2002;22:101-105.
12. Solomon LW, Fusman B, Jolly N, Kim A, Feldman T. Percutaneous suture closure for management of large French size arterial puncture in aortic valvuloplasty. J Invasive Cardiol 2001; 13:592-596.
13. Rahimtoola SH. Catheter balloon valvuloplasty for severe calcific aortic stenosis: A limited role. J Am Coll Cardiol 1994;23: 1076-1078.
14. Petrossian GA, Tuzcu EM, Ziskind AA, Block PC, Palacios I. Atrial septal occlusion improves the accuracy of mitral valve area determination following percutaneous mitral balloon valvotomy. Cathet Cardiovasc Diagn 1991;22:21-24.
15. Omran H, Schmidt H, Hackenbroch M, et al. Silent and apparent cerebral embolism after retrograde catheterisation of the aortic valve in valvular stenosis: A prospective, randomised study. Lancet 2003;361:1241-1246.
16. Reeder GS, Nishimura RA, Holmes DR Jr. Patient age and results of balloon aortic valvuloplasty: The Mansfield Scientific Registry experience. The Mansfield Scientific Aortic Valvuloplasty Registry Investigators. J Am Coll Cardiol 1991;17:909-913.
17. Agarwal A, Kini AS, Attanti S, Lee PC, Ashtiani R, Steinheimer AM, Moreno PR, Sharma SK. Results of repeat balloon valvuloplasty for treatment of aortic stenosis in patients aged 59 to 104 years. Am J Cardiol 2005;95:43-47.
18. Cribier A, Eltchaninoff H, Tron C, et al. Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. J Am Coll Cardiol 2004;43:698-703.
19. Webb JG, Chandavimol M, Thompson CR, Ricci DR, Carere RG, Munt BI, Buller CE, Pasupati S, Lichtenstein S. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation 2006;113:842-850.
20. Michaels AD, Ports TA. Use of a percutaneous arterial suture device (Perclose) in patients undergoing percutaneous balloon aortic valvuloplasty. Catheter Cardiovasc Interv 2001;53:445-447.
21. Mylonas I, Sakata Y, Salinger M, Sanborn TA, Feldman T. The use of percutaneous suture-mediated closure for the management of 14 French femoral venous access. J Invasive Cardiol 2006;18:299-302.